Leukemia Research
Volume 33, Issue 11 , Pages 1567-1569, November 2009

Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery

  • Hana Klamová

      Affiliations

    • Institue of Hematology and Blood Transfusion, U Nemocnice 1, 12820 Prague, Czech Republic
  • ,
  • Markéta Marková

      Affiliations

    • Institue of Hematology and Blood Transfusion, U Nemocnice 1, 12820 Prague, Czech Republic
  • ,
  • Jana Moravcová

      Affiliations

    • Institue of Hematology and Blood Transfusion, U Nemocnice 1, 12820 Prague, Czech Republic
  • ,
  • Magda Šišková

      Affiliations

    • 1st Medical Department – Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic
  • ,
  • Petr Cetkovský

      Affiliations

    • Institue of Hematology and Blood Transfusion, U Nemocnice 1, 12820 Prague, Czech Republic
  • ,
  • Kateřina Machová Poláková

      Affiliations

    • Institue of Hematology and Blood Transfusion, U Nemocnice 1, 12820 Prague, Czech Republic
    • Corresponding Author InformationCorresponding author. Tel.: +420 221 977 181; fax: +420 221 977 397.

Received 22 January 2009; received in revised form 14 May 2009; accepted 16 May 2009. published online 07 March 2011.

Abstract 

Here we report response to treatment of chronic myeloid leukemia (CML) of five pregnant women during and after pregnancy. CML was diagnosed during pregnancy in three patients. Pregnancy was confirmed during CML in two patients: in one in the 21st week of pregnancy while on imatinib, in another in the 12th week during the interferon treatment. Interferon with leukapheresis when needed was applied in the 2nd and 3rd trimester. All patients except one achieved complete hematological response during pregnancy. After delivery four patients achieved partial cytogenetic response on imatinib and two patients achieved major molecular response after crossover to dasatinib.

Keywords: CML, Pregnancy, Response, Therapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(09)00262-8

doi:10.1016/j.leukres.2009.05.012

Leukemia Research
Volume 33, Issue 11 , Pages 1567-1569, November 2009